[{"Assets_0_Q3_USD":"3198325000.0","CIK":"875320","CommonStockSharesIssued_0_Q3_shares":"252683346.0","CommonStockSharesOutstanding_0_Q3_shares":"252683346.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.41","EarningsPerShareBasic_3_Q3_USD":"0.66","EarningsPerShareDiluted_1_Q3_USD":"-0.41","EarningsPerShareDiluted_3_Q3_USD":"0.64","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","MinorityInterest_0_Q3_USD":"12167000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"617431000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-102952000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"162597000.0","NetIncomeLoss_1_Q3_USD":"-102952000.0","NetIncomeLoss_3_Q3_USD":"162800000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","ProfitLoss_1_Q3_USD":"-291267000.0","ProfitLoss_3_Q3_USD":"-10550000.0","RevenuesConverted_1_Q3_USD":"578165000.0","RevenuesConverted_3_Q3_USD":"1837018000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"1803244000.0","StockholdersEquity_0_Q3_USD":"1791077000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"250268000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"252095000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"250268000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"247963000.0","filed":"20171030","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20170930","qtrs":"0","uom":"USD"}]